Investor Presentaiton

INVESTOR 20 DAY 23 Grow profitable Therapy Selection business. Key financial targets Expand MRD reimbursement to increase ASP and accelerate volumes Balance rapid Screening revenue growth with measured spend Achieve >30% total revenue 5-year CAGR and >$2B in 2028 GUARDANT™ Reach cash flow breakeven by end of 2028 154

View entire presentation